Nobuaki Hamazaki1, Kentaro Kamiya2, Shohei Yamamoto3,4, Kohei Nozaki5, Takafumi Ichikawa5, Ryota Matsuzawa6, Masashi Yamashita3, Shota Uchida3, Emi Maekawa7, Kentaro Meguro7, Minako Yamaoka-Tojo2, Atsuhiko Matsunaga2, Junya Ako7. 1. Department of Rehabilitation, Kitasato University Hospital, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0375, Japan. hamanobu0317@gmail.com. 2. Department of Rehabilitation, Kitasato University School of Allied Health Sciences, Sagamihara, Japan. 3. Department of Rehabilitation Sciences, Kitasato University Graduate School of Medical Sciences, Sagamihara, Japan. 4. Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. 5. Department of Rehabilitation, Kitasato University Hospital, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0375, Japan. 6. Department of Physical Therapy, School of Rehabilitation, Hyogo University of Health Sciences, Kobe, Japan. 7. Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Abstract
AIMS: To investigate the impact of baseline kidney function on outcomes following comprehensive cardiac rehabilitation (CR) in patients with heart failure (HF). METHODS: We reviewed a total of 3,727 patients who were admitted for HF treatment. Estimated glomerular filtration rate (eGFR), quadriceps strength (QS), and 6-min walk distance (6MWD) were measured at hospital discharge as a baseline and 5 months thereafter in participants of outpatient comprehensive CR. The association between outpatient CR participation and all-cause events was evaluated using propensity score-matched analysis in subgroups across eGFR stages. The changes in QS and 6MWD following 5-month CR were compared between eGFR stages. RESULTS: Out of the studied patients, 1585 (42.5%) participated in outpatient CR. After propensity matching for clinical confounders, 2680 patients were included for analysis (pairs of n = 1340 outpatient CR participants and nonparticipants). The participation in outpatient CR was significantly associated with low clinical events in subgroups of eGFR ≥ 60 [hazard ratio (HR): 0.65, 95% confidence interval (CI): 0.51-0.84] and eGFR 45-60 (HR: 0.71, 95% CI: 0.55-0.92), but not in eGFR 30-45 (HR: 0.83, 95% CI: 0.64-1.08) and eGFR < 30 (HR: 0.88, 95% CI: 0.69-1.12). QS and 6MWD were significantly higher after 5-month CR than those at baseline (P < 0.001, respectively), but lower baseline eGFR correlated with lower changes in QS and 6MWD (trend P < 0.001, respectively). CONCLUSIONS: Although low baseline kidney function attenuates the outcomes of CR, outpatient CR seems to be associated with a better prognosis and positive change in physical function in HF patients with low kidney function.
AIMS: To investigate the impact of baseline kidney function on outcomes following comprehensive cardiac rehabilitation (CR) in patients with heart failure (HF). METHODS: We reviewed a total of 3,727 patients who were admitted for HF treatment. Estimated glomerular filtration rate (eGFR), quadriceps strength (QS), and 6-min walk distance (6MWD) were measured at hospital discharge as a baseline and 5 months thereafter in participants of outpatient comprehensive CR. The association between outpatient CR participation and all-cause events was evaluated using propensity score-matched analysis in subgroups across eGFR stages. The changes in QS and 6MWD following 5-month CR were compared between eGFR stages. RESULTS: Out of the studied patients, 1585 (42.5%) participated in outpatient CR. After propensity matching for clinical confounders, 2680 patients were included for analysis (pairs of n = 1340 outpatient CR participants and nonparticipants). The participation in outpatient CR was significantly associated with low clinical events in subgroups of eGFR ≥ 60 [hazard ratio (HR): 0.65, 95% confidence interval (CI): 0.51-0.84] and eGFR 45-60 (HR: 0.71, 95% CI: 0.55-0.92), but not in eGFR 30-45 (HR: 0.83, 95% CI: 0.64-1.08) and eGFR < 30 (HR: 0.88, 95% CI: 0.69-1.12). QS and 6MWD were significantly higher after 5-month CR than those at baseline (P < 0.001, respectively), but lower baseline eGFR correlated with lower changes in QS and 6MWD (trend P < 0.001, respectively). CONCLUSIONS: Although low baseline kidney function attenuates the outcomes of CR, outpatient CR seems to be associated with a better prognosis and positive change in physical function in HF patients with low kidney function.
Authors: Robert J Mentz; Jacob P Kelly; Thomas G von Lueder; Adriaan A Voors; Carolyn S P Lam; Martin R Cowie; Keld Kjeldsen; Ewa A Jankowska; Dan Atar; Javed Butler; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor Journal: J Am Coll Cardiol Date: 2014-11-24 Impact factor: 24.094
Authors: Andrew P Ambrosy; Hillary Mulder; Adrian Coles; William E Krauss; Carolyn S P Lam; Peter A McCullough; Ileana Pina; Jasper Tromp; David J Whellan; Christopher M O'Connor; Robert J Mentz Journal: Am J Cardiol Date: 2018-06-23 Impact factor: 2.778
Authors: Rod S Taylor; Linda Long; Ify R Mordi; Michael Tvilling Madsen; Edward J Davies; Hasnain Dalal; Karen Rees; Sally J Singh; Christian Gluud; Ann-Dorthe Zwisler Journal: JACC Heart Fail Date: 2019-07-10 Impact factor: 12.035
Authors: Andrew A House; Christoph Wanner; Mark J Sarnak; Ileana L Piña; Christopher W McIntyre; Paul Komenda; Bertram L Kasiske; Anita Deswal; Christopher R deFilippi; John G F Cleland; Stefan D Anker; Charles A Herzog; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Peter A McCullough Journal: Kidney Int Date: 2019-04-30 Impact factor: 10.612
Authors: Koen W Streng; Jan F Nauta; Hans L Hillege; Stefan D Anker; John G Cleland; Kenneth Dickstein; Gerasimos Filippatos; Chim C Lang; Marco Metra; Leong L Ng; Piotr Ponikowski; Nilesh J Samani; Dirk J van Veldhuisen; Aeilko H Zwinderman; Faiez Zannad; Kevin Damman; Peter van der Meer; Adriaan A Voors Journal: Int J Cardiol Date: 2018-07-07 Impact factor: 4.164
Authors: Christopher M O'Connor; David J Whellan; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston Miller; Jerome L Fleg; Kevin A Schulman; Robert S McKelvie; Faiez Zannad; Ileana L Piña Journal: JAMA Date: 2009-04-08 Impact factor: 56.272